Western Diet Decreases Hepatic Drug Metabolism in Male LDLr−/−ApoB100/100 Mice

Consumption of a Western diet is an important risk factor for several chronic diseases including nonalcoholic fatty liver disease (NAFLD), but its effect on the xenobiotic metabolizing enzyme activities in the liver has been studied incompletely. In this study, male LDLr−/−ApoB100/100 mice were fed...

Full description

Bibliographic Details
Main Authors: Markus Koponen, Jaana Rysä, Anna-Kaisa Ruotsalainen, Olli Kärkkäinen, Risto O. Juvonen
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Journal of Nutrition and Metabolism
Online Access:http://dx.doi.org/10.1155/2023/5599789
_version_ 1797850526707089408
author Markus Koponen
Jaana Rysä
Anna-Kaisa Ruotsalainen
Olli Kärkkäinen
Risto O. Juvonen
author_facet Markus Koponen
Jaana Rysä
Anna-Kaisa Ruotsalainen
Olli Kärkkäinen
Risto O. Juvonen
author_sort Markus Koponen
collection DOAJ
description Consumption of a Western diet is an important risk factor for several chronic diseases including nonalcoholic fatty liver disease (NAFLD), but its effect on the xenobiotic metabolizing enzyme activities in the liver has been studied incompletely. In this study, male LDLr−/−ApoB100/100 mice were fed with Western diet (WD) or a standard diet for five months to reveal the effects on drug metabolism such as cytochrome P450 (CYP) oxidation and conjugation activities in the liver. Hepatic steatosis, lobular inflammation, and early fibrosis were observed in WD fed mice, but not in chow diet control mice. When compared to the controls, the WD-fed mice had significantly decreased protein-normalized CYP probe activities of 7-ethoxyresorufinO-deethylation (52%), coumarin 7-hydroxylation (26%), 7-hydroxylation of 3-(3-fluoro-4-hydroxyphenyl)-6-methoxycoumarin (70%), 7-hydroxylation of 3-(4-trifluoromethoxyphenyl)-6-methoxycoumarin (78%), 7-hydroxylation of 3-(3-methoxyphenyl)coumarin (81%), and pentoxyresorufin O-depentylation (66%). Increased activity was seen significantly in sulfonation of 3-(4-methylphenyl)-7-hydroxycoumarin (289%) and cytosol catechol O-methyltranferase (COMT, 148%) in the WD group when compared to the controls. In conclusion, the WD-induced steatosis in male LDLr−/−ApoB100/100 mice was associated with decreased CYP oxidation reactions but had no clear effects on conjugation reactions of glucuronidation, sulfonation, and cytosolic catechol O-methylation. Consequently, the WD may decrease the metabolic elimination of drugs compared to healthier low-fat diets.
first_indexed 2024-04-09T19:02:55Z
format Article
id doaj.art-b5526ae210d343b097d23b7f8c997b98
institution Directory Open Access Journal
issn 2090-0732
language English
last_indexed 2024-04-09T19:02:55Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series Journal of Nutrition and Metabolism
spelling doaj.art-b5526ae210d343b097d23b7f8c997b982023-04-08T00:00:10ZengHindawi LimitedJournal of Nutrition and Metabolism2090-07322023-01-01202310.1155/2023/5599789Western Diet Decreases Hepatic Drug Metabolism in Male LDLr−/−ApoB100/100 MiceMarkus Koponen0Jaana Rysä1Anna-Kaisa Ruotsalainen2Olli Kärkkäinen3Risto O. Juvonen4School of PharmacySchool of PharmacyA. I. Virtanen Institute for Molecular SciencesSchool of PharmacySchool of PharmacyConsumption of a Western diet is an important risk factor for several chronic diseases including nonalcoholic fatty liver disease (NAFLD), but its effect on the xenobiotic metabolizing enzyme activities in the liver has been studied incompletely. In this study, male LDLr−/−ApoB100/100 mice were fed with Western diet (WD) or a standard diet for five months to reveal the effects on drug metabolism such as cytochrome P450 (CYP) oxidation and conjugation activities in the liver. Hepatic steatosis, lobular inflammation, and early fibrosis were observed in WD fed mice, but not in chow diet control mice. When compared to the controls, the WD-fed mice had significantly decreased protein-normalized CYP probe activities of 7-ethoxyresorufinO-deethylation (52%), coumarin 7-hydroxylation (26%), 7-hydroxylation of 3-(3-fluoro-4-hydroxyphenyl)-6-methoxycoumarin (70%), 7-hydroxylation of 3-(4-trifluoromethoxyphenyl)-6-methoxycoumarin (78%), 7-hydroxylation of 3-(3-methoxyphenyl)coumarin (81%), and pentoxyresorufin O-depentylation (66%). Increased activity was seen significantly in sulfonation of 3-(4-methylphenyl)-7-hydroxycoumarin (289%) and cytosol catechol O-methyltranferase (COMT, 148%) in the WD group when compared to the controls. In conclusion, the WD-induced steatosis in male LDLr−/−ApoB100/100 mice was associated with decreased CYP oxidation reactions but had no clear effects on conjugation reactions of glucuronidation, sulfonation, and cytosolic catechol O-methylation. Consequently, the WD may decrease the metabolic elimination of drugs compared to healthier low-fat diets.http://dx.doi.org/10.1155/2023/5599789
spellingShingle Markus Koponen
Jaana Rysä
Anna-Kaisa Ruotsalainen
Olli Kärkkäinen
Risto O. Juvonen
Western Diet Decreases Hepatic Drug Metabolism in Male LDLr−/−ApoB100/100 Mice
Journal of Nutrition and Metabolism
title Western Diet Decreases Hepatic Drug Metabolism in Male LDLr−/−ApoB100/100 Mice
title_full Western Diet Decreases Hepatic Drug Metabolism in Male LDLr−/−ApoB100/100 Mice
title_fullStr Western Diet Decreases Hepatic Drug Metabolism in Male LDLr−/−ApoB100/100 Mice
title_full_unstemmed Western Diet Decreases Hepatic Drug Metabolism in Male LDLr−/−ApoB100/100 Mice
title_short Western Diet Decreases Hepatic Drug Metabolism in Male LDLr−/−ApoB100/100 Mice
title_sort western diet decreases hepatic drug metabolism in male ldlr apob100 100 mice
url http://dx.doi.org/10.1155/2023/5599789
work_keys_str_mv AT markuskoponen westerndietdecreaseshepaticdrugmetabolisminmaleldlrapob100100mice
AT jaanarysa westerndietdecreaseshepaticdrugmetabolisminmaleldlrapob100100mice
AT annakaisaruotsalainen westerndietdecreaseshepaticdrugmetabolisminmaleldlrapob100100mice
AT ollikarkkainen westerndietdecreaseshepaticdrugmetabolisminmaleldlrapob100100mice
AT ristoojuvonen westerndietdecreaseshepaticdrugmetabolisminmaleldlrapob100100mice